The import of pharmaceutical products to Egypt stood at 2.7521 billion US Dollars in 2023. The year-on-year variation shows a relatively steady increase in the import values with fluctuations. Over the past two years, from 2022 to 2023, there was a year-on-year increase of 3.38% following a decline of 5.85% the previous year. Observing the trend from 2013 onwards, the imports have generally trended upwards with notable increases in some years. The Compound Annual Growth Rate (CAGR) over the last five years stood at 3.7%, reflecting moderate growth.
Looking ahead, the forecasted values suggest a continuous but slower growth towards 2028, with a predicted CAGR of 2.2% over the next five years. By 2028, the import value is expected to be around 3.1883 billion US Dollars, representing an overall growth rate of approximately 11.48% over the five-year forecast period.
Future trends to watch for include potential changes in regulatory policies affecting the import of pharmaceuticals, fluctuations in exchange rates, and any shifts in global pharmaceutical supply chains that may impact Egypt's import dynamics. Increased domestic production capacities and evolving healthcare demands will also play critical roles.
